Ruxandra Draghia-Akli
CIK: 0002041719
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NOVAVAX INC
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Mar 3, 2026NVAX
NOVAVAX INC
Exercise(M)Direct26.7K shares- - Mar 3, 2026NVAX
NOVAVAX INC
Tax Payment(F)Direct11.3K shares at avg. $9.49$107K - Mar 3, 2026NVAX
NOVAVAX INC
Disposition(D)DirectRestricted Stock Units
26.7K shares- - Mar 2, 2026NVAX
NOVAVAX INC
Award(A)DirectNon-Statutory Stock Option NQ
139.5K shares- - Mar 2, 2026NVAX
NOVAVAX INC
Award(A)DirectRestricted Stock Units
93K shares- - Mar 2, 2026NVAX
NOVAVAX INC
Award(A)DirectNon-Statutory Stock Opotion NQ
139.5K shares at avg. $9.09- - Nov 11, 2025NVAX
NOVAVAX INC
Tax Payment(F)Direct6K shares at avg. $7.40$45K - Nov 11, 2025NVAX
NOVAVAX INC
Disposition(D)DirectRestricted Stock Units
14.3K shares- - Nov 11, 2025NVAX
NOVAVAX INC
Exercise(M)Direct14.3K shares- - Mar 3, 2025NVAX
NOVAVAX INC
Award(A)Direct2025 Non-statutory Stock Option NQ
120K shares at avg. $7.87- - Mar 3, 2025NVAX
NOVAVAX INC
Award(A)Direct2025 Restricted Stock Units RSU
80K shares- - Nov 11, 2024NVAX
NOVAVAX INC
Award(A)DirectRestricted Stock Units
42.8K shares- - Nov 11, 2024NVAX
NOVAVAX INC
Award(A)DirectStock Option (Right to Buy)
64.2K shares at avg. $9.01-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 3, 2026 | NVAX NOVAVAX INC | Exercise(M) | 26,667 | - | $0 | Direct |
| Mar 3, 2026 | NVAX NOVAVAX INC | Tax Payment(F) | 11,313 | $9.49 | $107,360 | Direct |
| Mar 3, 2026 | NVAX NOVAVAX INC | Disposition(D) Restricted Stock Units | 26,667 | - | - | Direct |
| Mar 2, 2026 | NVAX NOVAVAX INC | Award(A) Non-Statutory Stock Option NQ | 139,500 | - | - | Direct |
| Mar 2, 2026 | NVAX NOVAVAX INC | Award(A) Restricted Stock Units | 93,000 | - | - | Direct |
| Mar 2, 2026 | NVAX NOVAVAX INC | Award(A) Non-Statutory Stock Opotion NQ | 139,500 | $9.09 | - | Direct |
| Nov 11, 2025 | NVAX NOVAVAX INC | Tax Payment(F) | 6,048 | $7.40 | $44,755 | Direct |
| Nov 11, 2025 | NVAX NOVAVAX INC | Disposition(D) Restricted Stock Units | 14,257 | - | - | Direct |
| Nov 11, 2025 | NVAX NOVAVAX INC | Exercise(M) | 14,257 | - | - | Direct |
| Mar 3, 2025 | NVAX NOVAVAX INC | Award(A) 2025 Non-statutory Stock Option NQ | 120,000 | $7.87 | - | Direct |
| Mar 3, 2025 | NVAX NOVAVAX INC | Award(A) 2025 Restricted Stock Units RSU | 80,000 | - | - | Direct |
| Nov 11, 2024 | NVAX NOVAVAX INC | Award(A) Restricted Stock Units | 42,770 | - | - | Direct |
| Nov 11, 2024 | NVAX NOVAVAX INC | Award(A) Stock Option (Right to Buy) | 64,150 | $9.01 | - | Direct |
1-13 of 13 transactions
About Draghia-Akli Ruxandra
Draghia-Akli Ruxandra (SEC CIK 0002041719) files insider reports with the SEC as EVP, Research & Development of NOVAVAX INC (NVAX).
Signal8 holds 6 ownership filings by Draghia-Akli Ruxandra (1 Form 3, 5 Form 4), filed between Nov 13, 2024 and Mar 9, 2026. Those filings report 13 transactions, from Nov 11, 2024 to Mar 3, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Draghia-Akli Ruxandra's filings is in GAITHERSBURG, MD.
Recent filings by Draghia-Akli Ruxandra
- Mar 3, 2026: Option exercise of NVAX shares (Form 4, code M).
- Mar 3, 2026: Tax withholding of NVAX shares (Form 4, code F).
- Mar 3, 2026: Disposition to issuer transaction of NVAX derivative securities (Form 4, code D).
- Mar 2, 2026: Grants or awards of NVAX derivative securities (3 lines, Form 4, code A).
- Nov 11, 2025: Tax withholding of NVAX shares (Form 4, code F).
Other insiders filing for NOVAVAX INC (NVAX)
- Rodgers Richard J, Director
- King Rachel K., Director
- DOUGLAS RICHARD, Director
- MCGLYNN MARGARET G, Director
- MOTT DAVID M, Director
- Alton Gregg H, Director